CHRONIC HEPATITIS C

This study tested whether adding an experimental drug called MP-424 to two standard hepatitis C medications could help patients whose infection returned after previous treatment. The trial involved 109 people with a specific type of hepatitis C who had relapsed. Researchers measu…

This study tested whether adding a new drug called MP-424 to two standard hepatitis C medications could help patients who had previously relapsed after treatment. The trial involved 108 people with a specific type of hepatitis C (genotype 2) who had seen their infection return af…

This study tested whether adding a new drug called MP-424 to two standard hepatitis C medications could help patients who didn't respond to prior treatment. It involved 10 people with a specific type of hepatitis C (genotype 2) that had resisted earlier therapy. The goal was to s…

This study tested whether higher doses of a medication called ursodeoxycholic acid (UDCA) were better than a low dose at improving liver health in people with chronic hepatitis C. Nearly 600 patients in Japan took part in this 24-week trial, where neither they nor their doctors k…

This was a very early study to check the safety and basic behavior of a new drug called MP-424 in people with a specific type of chronic Hepatitis C. It involved just 10 patients who had never taken certain other Hepatitis C medications. Researchers gave a single dose and then ca…